Printer Friendly

Browse Pharmaceutical industry topic

Licensing agreements subtopic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Redx Pharma strikes balance between in-house programmes and partnerships. Sep 12, 2020 648
Small Cap Movers: Drugs giant inks collaboration deal with artificial intelligence-driven diagnostics specialist, RenalytixAI. Aug 23, 2020 754
Dr. Reddy's Laboratories Launches Avigan in India. Aug 19, 2020 224
Eli Lilly, Innovent announce global expansion of TYVYT licensing agreement. Aug 18, 2020 410
Redx Pharma: the three-year journey from administration to FTSE 100 deal. Aug 15, 2020 1131
RedHill Biopharma and Cosmo Pharma sign licensing and manufacturing agreement. Aug 13, 2020 205
Small Cap Movers: Redx Pharma joins junior biotech success stories. Aug 9, 2020 894
Redx Pharma rockets as it licenses out novel IPF drug to AstraZeneca. Aug 5, 2020 388
Proactive news headlines: RedX Pharma, genedrive, Futura Medical, Open Orphan. Aug 5, 2020 1943
Redx Pharma PLC in a great place to move forward after Astra deal says CEO. Aug 5, 2020 199
Hanmi exports drug candidate material technology to MSD. Aug 4, 2020 269
Sesen Bio Inks Exclusive License Agreement with Qilu Pharmaceutical for the Development and Commercialisation of Vicineum in Greater China. Aug 3, 2020 872
Teva Partner Otsuka Files Japan New Drug Application for Ajovy Injection. Jul 31, 2020 221
Sangamo executes global licensing agreement with Novartis for genomic medicines. Jul 30, 2020 258
Avacta and Daewoong Pharmaceutical expand partnership to include COVID-19 neutralising Affimer Therapy. Jul 29, 2020 433
Bavarian Nordic signs final licensing agreement with AdaptVac on COVID-19 vaccine. Jul 23, 2020 327
Bavarian Nordic signs final licensing agreement with AdaptVac on COVID-19 vaccine. Jul 23, 2020 322
Bavarian Nordic signs final licensing agreement with AdaptVac on COVID-19 vaccine. Jul 23, 2020 326
Zymeworks announces new multispecific antibody collaboration with Merck. Jul 8, 2020 154
BioInvent International extends cancer immunotherapy research collaboration and license agreement term with Pfizer. Jul 2, 2020 197
BioInvent International extends cancer immunotherapy research collaboration and license agreement term with Pfizer. Jul 2, 2020 193
ABCELLERA SIGNS COLLABORATION AGREEMENT WITH LILLY. Jul 1, 2020 421
Merck, Ridgeback Biotherapeutics close collaboration, licensing deal. Jul 1, 2020 180
Dare Bioscience announces publication of article reviewing PCT studiesBayer. Jun 24, 2020 312
Dare Bioscience announces publication of article reviewing PCT studies. Jun 24, 2020 261
Dr. Reddy's Laboratories enters into a Licensing Agreement with Gilead Sciences for Remdesivir. Jun 16, 2020 219
Evox Therapeutics signs research collaboration and license agreement with Eli Lilly. Jun 10, 2020 218
Evox Therapeutics signs research collaboration and license agreement with Eli Lilly. Jun 10, 2020 214
AstraZeneca reaches 2bn capacity for coronavirus vaccine doses, receives more funds from Bill Gates' organisation. Jun 6, 2020 334
AstraZeneca reports 'steps towards broad and equitable access' to COVID vaccine. Jun 4, 2020 212
Jounce Therapeutics regains worldwide rights to JTX-8064 from Bristol-Myers. Jun 4, 2020 165
Ligand announces expansion of Icagen license agreement with Roche. May 29, 2020 166
Eden Research and Bayer Animal Health amend agreement. May 28, 2020 308
LAVA THERAPEUTICS COLLABORATES WITH JANSSEN. May 27, 2020 241
AGREEMENT EXPANDS GENPREX ONCOLOGY FRANCHISE. May 27, 2020 579
BLUSTER RISKS LOSING VACCINE; COVID-19 CRISIS: FEARS UK WILL GO TO BACK OF QUEUE FOR JABBritain-first boast could hamper access to treatment. EXCLUSIVE by ALAN SELBY May 24, 2020 333
BLUSTER RISKS LOSING VACCINE; Britain-first boast could hamper access to treatment. EXCLUSIVE BY ALAN SELBY May 24, 2020 333
Hopes for vaccine 'by September' PS84M MORE PUMPED INTO RESEARCH. GAVIN CORDON May 18, 2020 359
Further PS84m ploughed into search for vaccine. GAVIN CORDON Reporter May 18, 2020 563
Shot in the arm for vaccine hunt. May 18, 2020 388
UK steps up vaccine hunt as it pledges extra PS84m; CORONAVIRUS Government also investing millions in manufacturing centres. GAVIN CORDON May 18, 2020 426
PS84m extra for vaccine R&D at top universities. May 18, 2020 171
PS84m extra for vaccine R&D at top universities. May 18, 2020 155
UK to get 30million coronavirus vaccine doses 'by September' -if it works; An Oxford University team has signed a deal with pharma giant AstraZeneca which could mean a large delivery of doses this autumn. But it's 'a big if', Business Secretary Alok Sharma said. By, Dan Bloom May 17, 2020 1110
Pak to soon start manufacturing breakthrough Covid-19 treatment drug Remdesivir under license from US pharmaceutical company Gilead: Zafar Mirza. May 16, 2020 267
Cipla partners with Gilead to expand the access of Remdesivir to COVID-19. May 14, 2020 254
Cipla partners with Gilead to expand the access of Remdesivir to COVID-19. May 14, 2020 258
Ocular Therapeutix, Regeneron extend cooperation on eye treatment. May 14, 2020 283
Boehringer Ingelheim Collaborates with CDR-Life to Develop Antibody Fragment-based Therapeutics for Geographic Atrophy, a Leading Cause of Blindness Worldwide. May 14, 2020 351
Ferozsons subsidiary inks agreement with Gilead for manufacturing 'experimental drug' remdesivir. May 13, 2020 425
Covid-19: Gilead inks deal with Feronzsons for Remdesivir. May 13, 2020 313
Mylan to distribute investigational antiviral remdesivir for the potential treatment of COVID-19. May 13, 2020 189
Mylan to distribute investigational antiviral remdesivir for the potential treatment of COVID-19. May 13, 2020 185
AstraZeneca regains rights to Brazikumab from Allergan. May 12, 2020 196
AstraZeneca regains rights to Brazikumab from Allergan. May 12, 2020 192
Gilead signs remdesivir licensing deals with Mylan, four other manufacturers. May 12, 2020 177
Mylan to Supply Investigational Antiviral Remdesivir for the Potential Treatment of COVID-19. May 12, 2020 433
Aerpio amends licensing pact with Gossamer Bio on IBD candidate. May 12, 2020 174
Cocrystal reprioritizes development activities to accelerate COVID-19 program. May 11, 2020 621
BioMarin Pharmaceutical, DiNAQOR sign preclinical collaboration and license agreement. May 4, 2020 162
BioMarin Pharmaceutical, DiNAQOR sign preclinical collaboration and license agreement. May 4, 2020 158
ProThera Biologics, Takeda Enter Global Licensing Agreement to Develop Novel Plasma-Derived Therapy Based on Inter-alpha Inhibitor Proteins. Apr 27, 2020 548
ProThera Biologics signs licensing agreement with Takeda Pharmaceutical. Apr 24, 2020 164
ProThera Biologics signs licensing agreement with Takeda Pharmaceutical. Apr 24, 2020 168
Aytu BioScience announces exclusive ZolpiMist. Apr 8, 2020 156
Hikma wins litigation over heart disease prevention drug. Apr 1, 2020 227
SUDA Pharmaceuticals grants Mitsubishi Tanabe Korea an exclusive licence for ZolpiMist. Mar 24, 2020 326
Boehringer Ingelheim Enters Discovery Stage Collaboration with Trutino Biosciences. Mar 5, 2020 407
Hikma in nasal spray licence agreement, full-year profits soar. Feb 28, 2020 396
Hikma in nasal spray licence agreement, full-year profits soar. Feb 28, 2020 394
Karo Pharma reports on termination of agreement with Pfizer. Feb 5, 2020 161
Karo Pharma reports on termination of agreement with Pfizer. Feb 5, 2020 157
Genmab reports worldwide net trade sales of USD2.998bn for DARZALEX in 2019. Jan 23, 2020 291
EnWave Signs Technology License and Joint Development Agreement with GEA Lyophil GmbH to Advance REVa"[cent sign] Technology for Pharmaceutical Applications. Jan 23, 2020 983
Mereo Bio rises after signing licensing agreement with Oncologie Inc. Jan 14, 2020 1998
Ligand signs OmniAb Platform license agreement with Pandion Therapeutics for range of discovery programmes. Jan 14, 2020 181
Allele partners with Astellas for development of iPSC lines. Jan 14, 2020 187
Ligand signs OmniAb Platform license agreement with Pandion Therapeutics for range of discovery programmes. Jan 14, 2020 177
Allele partners with Astellas for development of iPSC lines. Jan 14, 2020 183
85 Biggest Movers From Yesterday. Lisa Levin Jan 14, 2020 2045
41 Stocks Moving In Monday's Mid-Day Session. Lisa Levin Jan 13, 2020 1177
UK WINNERS & LOSERS SUMMARY: Spirent Up After Lifting Profit Guidance. Jan 13, 2020 795
Axsome Therapeutics Enters into Exclusive License Agreement with Pfizer Inc. for Pfizer's Reboxetine Clinical and Nonclinical Data and for New Phase 3 Esreboxetine Product Candidate. Jan 13, 2020 2662
30 Stocks Moving In Monday's Mid-Day Session. Lisa Levin Jan 6, 2020 705
RedHill Biopharma Regains Rights to its Proprietary Bowel Preparation RHB-106. Jan 2, 2020 1391
Pulmatrix Shares Soar On Licensing Agreement With Johnson & Johnson. Shanthi Rexaline Jan 2, 2020 414
4 Stocks To Watch For December 24, 2019. Lisa Levin Dec 24, 2019 276
Lineage Cell Therapeutics Enters Into Three Separate License Agreements for Certain Intellectual Property and Assets. Dec 24, 2019 296
CytoDyn lands commercialization agreement with Vyera Pharmaceuticals to sell leronlimab to treat HIV. Dec 19, 2019 163
Alexion Exercises Option for Two Additional GalXC RNAi Programmes for Complement-Mediated Targets Under Collaboration with Dicerna. Dec 19, 2019 726
HitGen signs drug development license agreement with MTPC. Dec 18, 2019 144
HitGen signs drug development license agreement with MTPC. Dec 18, 2019 140
Ligand awards license to its worldwide OmniAb antibody discovery platform to Sanofi. Dec 3, 2019 216
Ligand awards license to its worldwide OmniAb antibody discovery platform to Sanofi. Dec 3, 2019 212
ImmuPharma's US licensing deal provides a path to commercialisation for flagship lupus drug. Nov 29, 2019 544
ViiV Healthcare plans to develop N6LS. Nov 25, 2019 265
ViiV Healthcare plans to develop N6LS. Nov 25, 2019 261
ViiV Healthcare announces exclusive licensing agreement with the National Institutes of Health for investigational "bNAb" with potential for long-acting HIV treatment and prevention. Nov 21, 2019 570
Arena Pharmaceuticals honoured by the California Life Sciences Association. Nov 19, 2019 261
Arena Pharmaceuticals honoured by the California Life Sciences Association. Nov 19, 2019 257
The Industry. Nov 14, 2019 2091
Regeneron (NASDAQ:REGN) - Regeneron And Vyriad Announce Strategic Agreement For Discovery And Development Of New Oncolytic Virus Treatments For Cancer -- 6/11/2019. Nov 11, 2019 549
Regeneron Pharmaceuticals signs research collaboration and option licensing agreement with Vyriad. Nov 8, 2019 153
Regeneron Pharmaceuticals signs research collaboration and option licensing agreement with Vyriad. Nov 8, 2019 149
The Industry. Nov 7, 2019 2089
Sun Pharma, AstraZeneca enter into license pact for novel oncology products in China. ANI Nov 6, 2019 310
Karo Phrama reports on termination of project by Pfizer regarding ROR-gamma. Nov 6, 2019 189
Karo Phrama reports on termination of project by Pfizer regarding ROR-gamma. Nov 6, 2019 185
Regeneron and Vyriad to co-develop new virus treatments for cancer. Nov 6, 2019 226
Antengene announces exclusive worldwide license from AstraZeneca for AZD0364. Nov 6, 2019 173
The Industry. Oct 24, 2019 2089
Pfizer Inc UK - Akcea And Pfizer Inc. Announce Licensing Agreement For Investigative Antisense Therapy Akcea-Angptl3-LRX -- 7/10/2019. Oct 15, 2019 431
Pfizer Inc. ( NYSE:PFE) - Akcea And Pfizer Inc. Announce Licensing Agreement For Investigative Antisense Therapy Akcea-Angptl3-LRx -- 7/10/2019. Oct 14, 2019 431
Shionogi partners with Hsiri Therapeutics Inc for research into therapeutics for non-tuberculous mycobacterial diseases and TB. Oct 11, 2019 220
Shionogi partners with Hsiri Therapeutics Inc for research into therapeutics for non-tuberculous mycobacterial diseases and TB. Oct 11, 2019 216
The Industry. Oct 10, 2019 2091
Akcea Therapeutics, Pfizer announces licensing agreement for AKCEA-ANGPTL3-L. Oct 7, 2019 229
Goldfinch Bio signs license agreement with Takeda Pharmaceutical Co. Oct 7, 2019 140
Goldfinch Bio signs license agreement with Takeda Pharmaceutical Co. Oct 7, 2019 136
The Industry. Oct 3, 2019 2091
Japan Pharmaceuticals Industry - Moberg Pharma and Taisho Sign Exclusive License Agreement for MOB-015 in Japan -- 30/9/2019. Oct 2, 2019 607
Indian Firms Ramp Up R&D: Accelerating on research spend. Harachand, S. Oct 1, 2019 705
SEBI imposes Rs 22.7 crore fine on Aurobindo Pharma for insider trading. ANI Sep 24, 2019 234
The Industry. Sep 20, 2019 2089
Bayer--Bayer and Informed Data Systems Inc. to develop One Drop digital therapeutics platform for multiple therapeutic areas--17/9/2019. Sep 19, 2019 305
Oncoheroes Biosciences Inc. and Boehringer Ingelheim International GmbH Sign Exclusive Licensing Agreement for Volasertib. Sep 19, 2019 408
The Industry. Sep 12, 2019 2093
Alexion Pharmaceuticals (NASDAQ: ALXN) - Alexion And BridgeBio Announce Japanese License Agreement For Eidos' Transthyretin Amyloidosis (ATTR) Investigational Medicine -- 9/9/2019. Sep 12, 2019 476
Boehringer Ingelheim signs licensing, development and commercialisation contract with Lupin. Sep 6, 2019 206
Boehringer Ingelheim signs licensing, development and commercialisation contract with Lupin. Sep 6, 2019 202
AstraZeneca signs IP agreement with Theragnostics. Sep 5, 2019 103
Biosynthetic Technologies Inks Patent License Agreement with Cayman Chemical for the Global Pharmaceutical and R&D Markets. Sep 5, 2019 624
The Industry. Sep 5, 2019 2088
Astellas Pharma Inc. - RIKEN and Astellas Enter into Worldwide Exclusive Licensing Agreement for Artificial Adjuvant Vector Cell Technology in Oncology -- 2/9/2019. Sep 3, 2019 687
The Industry. Aug 29, 2019 2090
Innovent Biologics signs licensing agreement with Eli Lilly. Aug 22, 2019 108
Innovent Biologics signs licensing agreement with Eli Lilly. Aug 22, 2019 104
Alligator Bioscience announces antibody agreement with Biotheus Inc for Greater China. Aug 21, 2019 185
Alligator Bioscience announces antibody agreement with Biotheus Inc for Greater China. Aug 21, 2019 181
LEO Pharma sub licenses rights to develop and market brodalumab for treating psoriasis outside of Europe. Aug 14, 2019 222
LEO Pharma sub licenses rights to develop and market brodalumab for treating psoriasis outside of Europe. Aug 14, 2019 218
Japanese Company Obtains License For Hearing Loss Treatment Candidate: Small-Molecule Drug Activates Inner Ear Progenitor Cells. Aug 12, 2019 428
Cocrystal Pharma reports Q2 revenue $592,000 vs. no revenue last year. Financial report Aug 9, 2019 111
Dechra Pharma To Work With Akston Biosciences On Dog Diabetes Drug. Aug 2, 2019 277
ASTELLAS AND FREQUENCY THERAPEUTICS PARTNER. Aug 1, 2019 682
BioInvent receives payment of USD300,000 from Pfizer on selection of first target under cancer immunotherapy agreement. Aug 1, 2019 168
BioInvent receives payment of USD300,000 from Pfizer on selection of first target under cancer immunotherapy agreement. Aug 1, 2019 169
BioInvent receives payment of USD300,000 from Pfizer on selection of first target under cancer immunotherapy agreement. Aug 1, 2019 164
The Industry. Aug 1, 2019 2089
Verastem, Sanofi sign licensing agreement. Jul 29, 2019 185
Verastem, Sanofi sign licensing agreement. Jul 29, 2019 181
Lexicon Shares Fall 47% On Termination Of License Agreement With Sanofi. Jul 29, 2019 189
Verastem Oncology Inks Exclusive License Agreement with Sanofi for the Development and Commercialisation of Copiktra in Russia and CIS, Turkey, the Middle East and Africa. Jul 29, 2019 372
Sanofi granted rights to develop and commercialise COPIKTRA from Verastem. Jul 26, 2019 239
Sanofi granted rights to develop and commercialise COPIKTRA from Verastem. Jul 26, 2019 235
Hikma Pharma Inks Africa And Middle East Commercial Deal With Gedeon. Jul 25, 2019 196
Verastem signs commercialization agreement with Sanofi for Copiktra in EMEA. Jul 25, 2019 146
Astellas Pharma Inc. - Astellas and Frequency Therapeutics Enter into License Agreement for FX-322, a Regenerative Treatment Candidate for Hearing Loss -- 17/7/2019. Jul 24, 2019 546
Crescendo Biologics' Second Oncology-targeted Humabody Licensed by Takeda. Jul 24, 2019 338
Jounce announces update on strategic collaboration with Celgene. Jul 23, 2019 300
Boehringer Ingelheim signs collaboration and licence agreement with Bridge Biotherapeutics. Jul 22, 2019 148
Boehringer Ingelheim signs collaboration and licence agreement with Bridge Biotherapeutics. Jul 22, 2019 144
Boehringer Ingelheim Expands Idiopathic Pulmonary Fibrosis Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics. Jul 19, 2019 289
Astellas and Frequency Therapeutics Enter into License Agreement for FX-322, a Regenerative Treatment Candidate for Hearing Loss. Jul 18, 2019 458
China Medical System Holdings Ltd. (0867. HK) Strategically Introduces Overseas Launched Blockbuster Innovative Products. Jul 16, 2019 2190
MacroGenics and I-Mab partner to develop and commercialize enoblituzumab in Greater China. Jul 11, 2019 241
MacroGenics and I-Mab partner to develop and commercialize enoblituzumab in Greater China. Jul 11, 2019 237
The Industry. Jul 11, 2019 2092
Nicox - Nicox Receives $3 Million Milestone Payment from Eyevance for ZERVIATETM in the U.S. -- 9/7/2019. Jul 11, 2019 239
Japan Pharmaceuticals Industry - Shionogi Concludes Licensing Agreements with Eddingpharm for Lusutrombopag, a Thrombopoietin Receptor Agonist -- 24/6/2019. Jul 9, 2019 1045
Boehringer Ingelheim Expands Nonalcoholic Steatohepatitis R and D Pipeline with New First-in-Class Compound from Yuhan Corp. Jul 5, 2019 409
Nicox - Nicox signs agreement for NCX 4251 in China with Ocumension Therapeutics for up to [euro]12 million in milestones plus royalties -- 2/7/2019. Jul 5, 2019 383
The Industry. Jul 4, 2019 2094
Boehringer Ingelheim signs collaboration and license agreement with Yuhan. Jul 4, 2019 202
Boehringer Ingelheim signs collaboration and license agreement with Yuhan. Jul 4, 2019 198
Japan Pharmaceuticals Industry - Shionogi Concludes Licensing Agreements with Eddingpharm for Lusutrombopag, a Thrombopoietin Receptor Agonist -- 24/6/2019. Jul 4, 2019 1079
Incyte partners with Zai Lab for INCMGA0012 in Greater China. Jul 3, 2019 219
Incyte partners with Zai Lab for INCMGA0012 in Greater China. Jul 3, 2019 215
Incyte, Zai Lab enter into collaboration, license agreement for INCMGA0012. Jul 2, 2019 133
The Industry. Jun 27, 2019 2089
Liquidia Technologies and GlaxoSmithKline restructure collaboration agreement. Jun 26, 2019 190
Japan Pharmaceuticals Industry - Shionogi Concludes Licensing Agreements with Eddingpharm for Lusutrombopag, a Thrombopoietin Receptor Agonist -- 24/6/2019. Jun 25, 2019 1003
The Industry. Jun 21, 2019 2093
The Industry. Jun 13, 2019 2090
Deciphera Pharmaceuticals, Zai Lab Ink Exclusive License Agreement for Ripretinib in Greater China. Jun 13, 2019 539
Mesoblast and JCR Pharma expand partnership in Japan to the use of MSCs. Jun 11, 2019 226
Deciphera, Zai Lab announce ripretinib license agreement in Greater China. Jun 11, 2019 169
Deciphera, Zai Lab announce exclusive license agreement for ripretinib. Jun 11, 2019 170
The Industry. Jun 7, 2019 2089
Eli Lilly & Company (NYSE: LLY) - Lilly Announces Licensing Agreement for Non-Opioid Pain Asset from Centrexion Therapeutics -- 28/5/2019. Jun 4, 2019 351
VECTURA (LSE: VEC) - Vectura receives $2.5m milestone payment for the European regulatory submission of QVM149 -- 24/5/2019. Jun 4, 2019 252
Starpharma enters into second DEP oncology agreement with AstraZeneca. Jun 4, 2019 204
Starpharma enters into second DEP oncology agreement with AstraZeneca. Jun 4, 2019 200
Boehringer Ingelheim signs second collaboration and license agreement with Gubra. May 31, 2019 199
Boehringer Ingelheim signs second collaboration and license agreement with Gubra. May 31, 2019 195
ADC Therapeutics Expands to Third Programme Using Synaffix's ADC Platform Under Existing Agreement. May 30, 2019 362
Zymeworks achieves USD2.0m milestone payment from Merck. May 29, 2019 181
Zymeworks achieves USD2.0m milestone payment from Merck. May 29, 2019 177
VECTURA (LSE: VEC) - Vectura receives $2.5m milestone payment for the European regulatory submission of QVM149 -- 24/5/2019. May 29, 2019 252
Ligand Pharmaceuticals grants Cumulus Oncology rights to develop and commercialise VER250840. May 21, 2019 162
Ligand Pharmaceuticals grants Cumulus Oncology rights to develop and commercialise VER250840. May 21, 2019 158
Eisai Co., Ltd. - Eisai Enters Into Licensing Agreement With Medac Concerning Anti-Rheumatic Agent Methotrexate Subcutaneous Injection In Japan -- 10/5/2019. May 15, 2019 515
Eisai Europe - Eisai Enters Into Licensing Agreement With Medac Concerning Anti-Rheumatic Agent Methotrexate Subcutaneous Injection In Japan -- 10/5/2019. May 15, 2019 328
GlycoMimetics Completes Enrollment for Phase 3 Clinical Trial Evaluating Rivipansel in Sickle Cell Disease. May 8, 2019 560
Transgene signs collaborative research, option and exclusive license agreement with AstraZeneca. May 6, 2019 222
Transgene signs collaborative research, option and exclusive license agreement with AstraZeneca. May 6, 2019 218
GlycoMimetics completes enrollment for Phase 3 trial evaluating rivipansel. May 6, 2019 161
Emendo Biotherapeutics signs licensing option agreement with Takeda. Apr 25, 2019 204
Emendo Biotherapeutics signs licensing option agreement with Takeda. Apr 25, 2019 200
HitGen signs drug development licence agreement with Kaken. Apr 11, 2019 153
HitGen signs drug development licence agreement with Kaken. Apr 11, 2019 149
Xencor and Astellas Enter Collaboration for Novel Bispecific Antibody Program. Apr 3, 2019 234
Vect-Horus Enters Collaboration and License Agreement with Ono Pharmaceutical. Mar 28, 2019 248
Ichor Medical Systems Forges Collaboration and Research License Agreement with AstraZeneca to Develop DNA-based Monoclonal Antibody Platform. Mar 28, 2019 342
Lilly signs licensing and research collaboration with ImmuNext. Mar 27, 2019 199
Lilly signs licensing and research collaboration with ImmuNext. Mar 27, 2019 195
LegoChem Biosciences partners with Takeda for development of antibody-drug conjugates in immuno-oncology. Mar 22, 2019 202
LegoChem Biosciences partners with Takeda for development of antibody-drug conjugates in immuno-oncology. Mar 22, 2019 198
Enigma Biomedical Inks License Agreement with US Merck for Novel MK-6884 Imaging Agent. Mar 19, 2019 308
Enigma Biomedical Group & Merck partnership to develop novel imaging agent MK-6884. Mar 18, 2019 233
Enigma Biomedical Group & Merck partnership to develop novel imaging agent MK-6884. Mar 18, 2019 229
Japanese Firms Test Dental Pulp Stem Cell-based Product In Clinical Trial. Mar 18, 2019 335
Japanese Firms Test Dental Pulp Stem Cell-based Product In Clinical Trial. Mar 18, 2019 333
Japanese Clinical Trial Tests Dental Pulp Stem Cell-based Stroke Treatment. Mar 11, 2019 333
Infinity Pharmaceuticals announces royalty monetization of $30M from Verastem. Mar 6, 2019 166
Principia Biopharma presents Phase 1 PRN2246 data at ACTRIMS. Mar 1, 2019 286
Moberg Pharma announces signing of exclusive license agreement with Bayer for commercialisation of MOB-015 in Europe. Feb 12, 2019 191
Moberg Pharma announces signing of exclusive license agreement with Bayer for commercialisation of MOB-015 in Europe. Feb 12, 2019 187
Moberg Pharma, Bayer sign exclusive license agreement for MOB-015 in Europe. Feb 11, 2019 168
Janssen Pharmaceuticals signs contract with MeiraGTx. Feb 4, 2019 169
Janssen Pharmaceuticals signs contract with MeiraGTx. Feb 4, 2019 165
Johnson & Johnson subsidiary enters collaboration with MeiraGTx. Jan 31, 2019 132
Merck KGaA grants license to Vertex for two DNA damage response inhibitors. Jan 24, 2019 134
Ablexis Expands Non-Exclusive Perpetual License Agreement with Eli Lilly and Company. Jan 18, 2019 234
Biomunex Pharmaceuticals signs licensing agreement with Sanofi. Jan 17, 2019 161
Biomunex Pharmaceuticals signs licensing agreement with Sanofi. Jan 17, 2019 157
Bioharmony Therapeutics, Boehringer Ingelheim Team to Advance Bacteriophage Lysin Therapeutics for the Treatment of Multi-Drug Resistant Bacterial Infections. Jan 16, 2019 337
Alopexx Vaccine enters into equine vaccine licensing agreement with Merck Animal Health. Jan 15, 2019 230
China's Bio-Thera Solutions Partners with Cipla to Market Key Cancer Biosimilar. Jan 14, 2019 377
4D pharma names new independent non-executive directors. Jan 9, 2019 168
4D pharma names new independent non-executive directors. Jan 9, 2019 164
CANbridge Pharmaceuticals and GC Pharma Ink Greater China Licensing Agreement for Hunterase for Hunter Syndrome. Jan 9, 2019 414
Boehringer Ingelheim exercises option to receive exclusive rights to second hepatic disease target from Dicerna collaboration. Jan 8, 2019 251
Boehringer Ingelheim exercises option to receive exclusive rights to second hepatic disease target from Dicerna collaboration. Jan 8, 2019 247
Xencor regains ex-U.S. commercial rights to XmAb13676 from Novartis. Jan 7, 2019 106
Amunix signs therapeutics licensing agreement with Merck. Jan 4, 2019 160
Amunix signs therapeutics licensing agreement with Merck. Jan 4, 2019 156
MyoKardia regains rights to all programs under Sanofi license agreement. Jan 2, 2019 356
Opiant Pharmaceuticals signs licensing agreement with Sanofi. Dec 28, 2018 131
Opiant Pharmaceuticals signs licensing agreement with Sanofi. Dec 28, 2018 127
Ayala Pharmaceuticals to Develop and Commercialise AL102 in Combination with BCMA Targeting Agents in Multiple Myeloma. Dec 26, 2018 415
Neos Therapeutics and Teva settle XR-ODT patent litigation case. Dec 26, 2018 112
Opiant Pharmaceuticals licenses drinabant for ACO from Sanofi. Dec 26, 2018 244
Merus announces global settlement and ends litigation with Regeneron. Dec 20, 2018 134
Kineta Immuno-Oncology signs research collaboration with Pfizer. Dec 18, 2018 213
Kineta Immuno-Oncology signs research collaboration with Pfizer. Dec 18, 2018 209
Eli Lilly, Aduro Biotech announce research collaboration, license agreement. Dec 18, 2018 194
Eli Lilly, Aduro announce research collaboration for immunotherapy development. Dec 18, 2018 225
Kineta unit enters license agreement with Pfizer to develop cancer treatment. Dec 17, 2018 158
Eli Lilly, AC Immune to develop tau aggregation inhibitor small molecules. Dec 12, 2018 262
AC Immune, Eli Lilly announce license and collaboration agreement. Dec 12, 2018 265
Licensed brands give clout to variety of products. Dec 10, 2018 595
AbbVie signs HUMIRA global patent license with Pfizer. Dec 3, 2018 168
AbbVie signs HUMIRA global patent license with Pfizer. Dec 3, 2018 164
Advanced Accelerator, FUJIFILM Toyama Chemical sign option, license agreement. Dec 3, 2018 161
Argenx enters exclusive global collaboration, license agreement with Cilag. Dec 3, 2018 207
Argenx price target raised to $161 from $154 at Piper Jaffray. Dec 3, 2018 117
AbbVie signs patent license agreements with Pfizer over Humira biosimilar. Nov 30, 2018 139
$32 million court ruling in AbbVie drug case. Nov 29, 2018 363
Regulus amends and restructures agreement with Sanofi. Nov 6, 2018 122
Eli Lilly signs global licensing and research collaboration with Dicerna Pharmaceuticals. Oct 31, 2018 211
Eli Lilly signs global licensing and research collaboration with Dicerna Pharmaceuticals. Oct 31, 2018 207
Rigel Pharmaceuticals Inc signs exclusive license and supply agreement with Kissei Pharmaceutical Co Ltd. Oct 30, 2018 216
Rigel Pharmaceuticals Inc signs exclusive license and supply agreement with Kissei Pharmaceutical Co Ltd. Oct 30, 2018 212
Bristol-Myers Squibb doses first patient in clinical trial of BMS-986179. Oct 29, 2018 195
Bristol-Myers Squibb doses first patient in clinical trial of BMS-986179. Oct 29, 2018 191
Alvit LCS Pharma signs medical cannabis manufacturing and licensing agreement with Bazelet for Israel. Oct 25, 2018 197
Alvit LCS Pharma signs medical cannabis manufacturing and licensing agreement with Bazelet for Israel. Oct 25, 2018 193
Bristol-Myers doses first subject in Phase 1 trial using Halozyme's Enhanze. Oct 25, 2018 153
Boston Pharmaceuticals signs licensing and equity agreement with Novartis. Oct 5, 2018 208
Boston Pharmaceuticals signs licensing and equity agreement with Novartis. Oct 5, 2018 204
Arrowhead price target raised to $25 from $17 at Piper Jaffray. Oct 4, 2018 106
Axcelead Drug Discovery Partners and ERS Genomics Enter into CRISPR/Cas9 License Agreement. Oct 4, 2018 355
GO Therapeutics Enters into a License Agreement with Roche for New Glycotargeting Bispecific Cancer Treatment. Oct 3, 2018 208
Aduro dropped 13% after Janssen terminated license agreements. Oct 3, 2018 195
Janssen termination inconsequential for Aduro Biotech, says William Blair. Oct 3, 2018 128
Cellular signs licensing and collaboration agreement with Novartis in China. Sep 27, 2018 114
Eli Lilly, Chugai enter into license pact for OWL833. Sep 26, 2018 168
ITM and Merck KGaA Sign Research Evaluation and Option Agreement to Develop Folate Receptor Targeted Radionuclide Therapy. Sep 18, 2018 386
Novocure, Zai Lab announce strategic collaboration for Tumor Treating Fields. Sep 12, 2018 295
Novocure and Zai Lab Ink License Agreement for Tumor Treating Fields in Greater China. Sep 12, 2018 668
Active Biotech announces regain of global rights to development and commercialisation of laquinimod from Teva. Sep 6, 2018 252
Active Biotech announces regain of global rights to development and commercialisation of laquinimod from Teva. Sep 6, 2018 253
Biohaven Licenses Novel Myeloperoxidase Inhibitor from AstraZeneca: Potential First-In-Class Treatment for Multiple System Atrophy. Sep 6, 2018 479
JW Pharmaceutical Inks Global Out-Licensing Deal for Novel Atopic Dermatitis Drug Candidate. Aug 24, 2018 388
Cancer Prevention Pharmaceuticals signs licensing deal with Mallinckrodt for North America. Aug 14, 2018 234
Cancer Prevention Pharmaceuticals signs licensing deal with Mallinckrodt for North America. Aug 14, 2018 230
Shire and Shionogi submit New Drug Application for INTUNIV in Japan. Aug 13, 2018 182
Shire and Shionogi submit New Drug Application for INTUNIV in Japan. Aug 13, 2018 178
Perrigo Company plc announces licensing agreement in the US for Nasonex Nasal Spray under Rx-To-OTC Switch strategy. Aug 9, 2018 208

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters